RNA, U6 small nuclear 195, pseudogene (RNU6-195P)

RNU6-195P is a pseudogene belonging to the U6 small nuclear RNA (snRNA) family. U6 snRNA is a component of the spliceosome, which is responsible for the removal of introns from pre-mRNA during splicing in eukaryotic cells[1][2]. However, the RNU6-195P pseudogene does not produce a functional U6 snRNA molecule and does not participate in splicing or any other known biological process. Pseudogenes like RNU6-195P arise from duplication or retrotransposition events and typically lack regulatory elements or harbor disabling mutations, meaning they do not generate active transcripts or functional products. RNU6-195P should not be confused with functional U6 snRNA genes, which are essential for spliceosomal activity[1][2][3]. There is no documented role for RNU6-195P in disease, drug targeting, or as a diagnostic or prognostic biomarker. No therapies or mechanisms of action are associated, nor are there safety concerns, since it is not a therapeutic target. It is primarily of interest as a genomic annotation, not as a drug discovery or clinical entity.

Other names

RNU6-195PRNA, U6 small nuclear 195, pseudogene

None (not druggable or targeted)